ArticleCureus2025
Use of Tissue Expander and Breast Implant in Postmastectomy Reconstruction: Presentation of a Clinical Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains the most common malignancy among women worldwide, and mastectomy continues to be a standard treatment for many patients. Advances in oncological therapies have led to increased survival rates, emphasizing the need for reconstructive options that not only restore physical anatomy but also improve psychological well-being and overall quality of life. Breast reconstruction using tissue expanders has become a widely accepted technique, offering a staged approach that allows gradual accommodation of an implant while preserving the skin and soft tissue envelope. This method is particularly beneficial in cases where autologous tissue is insufficient or when patients prefer a less invasive initial procedure. Technological innovations have led to the development of anatomically shaped expanders and integrated valve systems, enhancing both safety and aesthetic outcomes. Despite its advantages, expander-based reconstruction is not without complications, with risks such as infection, extrusion, capsular contracture, and delayed wound healing, particularly in patients undergoing adjuvant radiotherapy. Successful outcomes depend largely on appropriate patient selection, meticulous surgical technique, and careful postoperative management. The use of acellular dermal matrices and advances in expander design have further expanded the possibilities for optimizing results. Tissue expander breast reconstruction remains a safe, effective, and customizable option for many breast cancer survivors. As research progresses, future innovations in biomaterials, surgical techniques, and adjuvant therapies are expected to continue improving the durability, safety, and aesthetic satisfaction of reconstructive outcomes, ultimately contributing to better long-term physical and psychological recovery for patients following breast cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.